Skip to main content
Premium Trial:

Request an Annual Quote

AltheaDx, Compendia Partner on Breast Cancer Assay

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AltheaDx today said that it has formed a partnership with Compendia Bioscience to combine their technologies to create tests that can predict patient outcomes in clinical trials.

The initial product developed under the collaboration is the Breast Cancer Segregation Panel Assay — a real-time, PCR-based panel that has been optimized for analysis of RNA extracted from formalin-fixed, paraffin-embedded tissue. The panel includes 96 genes associated with breast cancer identified through a meta-analysis of cancer genomic data from more than 5,000 clinical samples, said AltheaDx.

Under the collaboration, AltheaDx will process and analyze samples at its San Diego-based CLIA and GLP lab. Compendia will manage downstream data analysis and statistical correlation to patient outcomes in clinical trials.

The firms also said that they plan to develop Segregation Panels for other cancer types, with the launch of a Colorectal Cancer Segregation Panel expected to be launched in 2011.

Further terms of the alliance were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.